0611 The Safety and Tolerability of Pitolisant in the Treatment of Excessive Daytime Sleepiness and Cataplexy in Adult Patients With Narcolepsy: An Open-Label, Expanded Access Program in the United States
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.